Fruquintinib with PD-1 inhibitors versus fruquintinib monotherapy in late-line mCRC: A retrospective cohort study based on propensity score matching. This is an ASCO Meeting Abstract from the 2024 ...

The U.S. Food and Drug Administration is warning pet owners of the risks associated with a skin cancer cream after five dogs were died after accidentally ingesting it. The topical cancer medication ...

Phase I Trial of Systemic Oxaliplatin Combination Chemotherapy With Hepatic Arterial Infusion in Patients With Unresectable Liver Metastases From Colorectal Cancer Two hundred forty-nine patients with ...

Fluorouracil is not recommended for use in patients known to have certain homozygous or compound heterozygous DPYD variants that result in complete DPD deficiency. The Food and Drug Administration ...

Fluorouracil (5FU) is a type of chemotherapy used to help treat several types of cancer. Side effects may include dizziness, nausea, and low blood count, among others. Cancer is a disease where cells ...

Review the side-effects of Fluorouracil as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. KOLOA, Hawaii — The use of topical 5-fluorouracil ...

Fluorouracil (Fluracil) is an antimetabolite, prescribed for certain types of cancer such as colon, rectal, breast, stomach and pancreatic cancer. It works by blocking the growth of certain cells. The ...

The FDA has received reports of dogs dying after they were exposed to a type of medicated cream called fluorouracil. If your medication contains fluorouracil, you should move it somewhere out of reach ...

Actinic keratoses are common in older individuals and topical immunotherapy is an important treatment when multiple lesions are present. To assess the efficacy of 5-fluorouracil in treating actinic ...

Oncology specialists should inform patients about a risk of serious toxicity related to dihydropyrimidine dehydrogenase (DPD) deficiency and should test for DPYD variants before starting treatment ...